What the experts say…

Ulrik Tarp,
MD DMSc 

Chief Consultant, Associate Professor. Department of Rheumatology, Aarhus University Hospital.

It is my strong belief that development of a technology for patient self-monitoring of biomarkers which can indicate the presence and progression of rheumatic diseases has very significant clinical and market potential

Michael Borre,
MD Professor

Senior consultant, PhD, DMSc, Department of Urology, Aarhus University Hospital.

Today we schedule patients to appear in our out-patient clinic on a quarterly basis for follow-up investigations, including PSA measurement at the central laboratory. These patients would receive a much better and safer monitoring if they could perform such monitoring themselves at home

Lars J. Østergaard,
MD DMSc 

Professor of Infectious Medicine, Aarhus University Hospital.

 We often see patients for frequent out-patient visits or even admit them to hospital for monitoring or progress of infectious diseases. If these patients could perform such monitoring themselves at home and they would be able to communicate their data to the hospital we would be able to offer these patients a much better, safer and much more careful monitoring and even use our resources in a much more intelligent way